52094-01-6 Usage
Explanation
The full name of the compound, indicating its structure and stereochemistry.
Explanation
Belongs to the class of carbon-containing compounds.
Explanation
Acts as a medium to dissolve other substances, facilitating chemical reactions.
Explanation
The compound is relatively unreactive and does not easily undergo decomposition or change.
Explanation
Does not readily evaporate at room temperature, making it suitable for certain applications.
Explanation
Indicates the specific spatial arrangement of atoms in the molecule, which can affect its reactivity and biological activity.
Explanation
Utilized in the production of various chemicals and products due to its solvent properties and stability.
Explanation
Due to potential hazards and risks, it is essential to follow proper safety measures when working with 1,3-Dioxolane, 2,2-dimethyl-4-[(2-methylphenoxy)methyl]-, (S)-.
Explanation
The compound may pose health or environmental risks if not handled or disposed of properly.
Classification
Organic compound
Solvent
Used in various industrial processes
Stability
Known for its stability
Low Volatility
Low volatility
Stereochemistry
(S)designation
Applications
Manufacturing of pharmaceuticals, agrochemicals, and specialty chemicals
Safety
Handle with care and in accordance with safety guidelines
Potential Hazards
Potential hazards and risks
Check Digit Verification of cas no
The CAS Registry Mumber 52094-01-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,2,0,9 and 4 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 52094-01:
(7*5)+(6*2)+(5*0)+(4*9)+(3*4)+(2*0)+(1*1)=96
96 % 10 = 6
So 52094-01-6 is a valid CAS Registry Number.
52094-01-6Relevant academic research and scientific papers
Cardiovascular hybrid drugs: New benzazepinone derivatives as bradycardic agents endowed with selective β1-Non-competitive antagonism
Bisi, Alessandra,Rampa, Angela,Budriesi, Roberta,Gobbi, Silvia,Belluti, Federica,Ioan, Pierfranco,Valoti, Ermanno,Chiarini, Alberto,Valenti, Piero
, p. 1353 - 1361 (2007/10/03)
The synthesis and pharmacological profile of some hybrid compounds bearing both the benzazepinone moiety present in Zatebradine and typical β-blocker aryloxypropanolamine groups are described. The new compounds proved to be endowed with negative chronotropic and inotropic activity and are weak vasorelaxant agents. The cardiodepressant action is probably due to selective β1-noncompetitive reversible antagonism. Both enantiomers of the most active compound 5c were synthesized and they showed a different cardiovascular profile, that is (+)-(R)-enantiomer displays affinity for cardiac β1-adrenoceptors, while (-)-(S)-enantiomer shows specificity for vessel smooth muscle.
